ARVINAS, INC. Accrued Liabilities, Current
ARVINAS, INC. (ARVN) had Accrued Liabilities, Current of $30.20 million as of 2022-03-31, per its 10-Q filed 2022-05-05.
Discontinued › Balance Sheet › Liabilities
us-gaap:AccruedLiabilitiesCurrent · last filed 2022-05-05
- 2022-03-31: Accrued Liabilities, Current $30.20M.
- 2021-12-31: Accrued Liabilities, Current $23.10M.
- 2021-09-30: Accrued Liabilities, Current $13.77M.
- 2021-06-30: Accrued Liabilities, Current $13.47M.
| Period end | Accrued Liabilities, Current | Accrued Liabilities, Current as first filed |
|---|---|---|
| 2022-03-31 | $30.20M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $23.10M 10-Q · filed 2022-05-05 | |
| 2021-09-30 | $13.77M 10-Q · filed 2021-11-03 | |
| 2021-06-30 | $13.47M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $8.00M 10-Q · filed 2021-05-04 | |
| 2020-12-31 | $18.90M 10-K · filed 2022-02-28 | $18.86M 10-K · filed 2021-03-01 |
| 2020-09-30 | $12.14M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $7.40M 10-Q · filed 2020-08-04 | |
| 2020-03-31 | $6.78M 10-Q · filed 2020-04-28 | |
| 2019-12-31 | $7.60M 10-K · filed 2021-03-01 | |
| 2019-09-30 | $6.23M 10-Q · filed 2019-11-04 | |
| 2019-06-30 | $4.00M 10-Q · filed 2019-08-05 | |
| 2019-03-31 | $2.95M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $4.00M 10-K · filed 2020-03-16 | |
| 2018-09-30 | $4.85M 10-Q · filed 2018-11-14 | |
| 2017-12-31 | $3.55M 10-K · filed 2019-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 |